Company Overview
Pihlajalinna is a leading Finnish provider of social and healthcare services, specializing in medical care, rehabilitation, and wellness. With a strong focus on innovation and customer satisfaction, the company aims to improve the lives of its clients through high-quality services. Pihlajalinna's mission is to become the most popular healthcare service provider in Finland, known for its expertise, reliability, and commitment to excellence. The company's core values include empathy, professionalism, and a passion for delivering exceptional patient care. By prioritizing these values, Pihlajalinna strives to create a positive impact on its clients' well-being and overall quality of life.Primary Mission and Core Values
Pihlajalinna's primary mission is to provide high-quality healthcare services that meet the evolving needs of its clients. The company's core values are rooted in its commitment to delivering exceptional patient care, which includes: Empathy: Pihlajalinna prioritizes understanding and empathy towards its clients, recognizing their unique needs and concerns. Professionalism: The company maintains a high level of professionalism among its staff, ensuring that every client receives expert care and attention. Passion for excellence: Pihlajalinna is dedicated to delivering exceptional services that exceed its clients' expectations.Key Products/Services
Pihlajalinna offers a range of key products and services, including: Medical care: The company provides comprehensive medical care services, including primary care, specialist care, and hospitalization. Rehabilitation: Pihlajalinna offers rehabilitation services to help clients recover from illness or injury, promoting physical and mental well-being. Wellness: The company provides wellness programs and services aimed at improving clients' overall health and quality of life. These products and services are designed to benefit clients in various ways, including: Improved health outcomes Enhanced quality of life Increased independence and mobility Reduced risk of chronic diseasesBenefits
Pihlajalinna's products and services offer numerous benefits, including: Personalized care: The company's focus on empathy and understanding ensures that every client receives tailored care that meets their unique needs. Expertise: Pihlajalinna's staff are highly trained professionals with extensive experience in delivering exceptional patient care. Convenience: The company offers a range of services, including online consultations and home visits, to make healthcare more accessible and convenient. By investing in Pihlajalinna, you can tap into the company's expertise, commitment to excellence, and passion for delivering exceptional patient care.Valuation
| 2022 | 2023 | 2024 | 2025 | 2026 (e) | 2027 (e) | 2028 (e) | |
|---|---|---|---|---|---|---|---|
| Number of Shares (million) | 22.5 | 22.6 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 |
| Target Valuation (MEur) | 417.7 | 343.0 | 407.2 | 488.9 | 492.9 | 492.3 | 492.3 |
| Targer Price | 18.52 | 15.2 | 18.11 | 21.75 | 21.93 | 21.9 | 21.9 |
| Potential, % | 117.4 | 115.3 | 72.5 | 49.0 | 107.6 | 107.4 | 107.4 |
| Recommendation | Buy | Buy | Buy | Buy | Buy | Buy | Buy |
| MCAP (MEur) | 192.1 | 159.3 | 236.0 | 328.2 | 237.4 | 237.4 | 237.4 |
| Price | 8.52 | 7.06 | 10.5 | 14.6 | 10.56 | 10.56 | 10.56 |
| EV | 578.0 | 512.0 | 533.0 | 600.0 | 503.0 | 471.0 | 443.0 |
| P/S | 0.28 | 0.22 | 0.34 | 0.5 | 0.41 | 0.4 | 0.4 |
| EV/S | 0.84 | 0.71 | 0.76 | 0.92 | 0.86 | 0.79 | 0.75 |
| EV/EBIT | 64.92 | 24.86 | 10.98 | 11.36 | 10.67 | 10.2 | 10.57 |
| P/E | 25.28 | 34.63 | 7.84 | 8.5 | 6.48 | 6.43 | 7.08 |
| P/B | 1.55 | 1.08 | 1.4 | 1.7 | 1.23 | 1.03 | 0.9 |
| P/OCF | 2.96 | 2.1 | 2.34 | 4.34 | 4.9 | 5.15 | 5.8 |
| EV/OCF | 8.89 | 6.75 | 5.29 | 7.94 | 10.39 | 10.21 | 10.84 |
| P/FCF | -10.44 | 2.77 | 2.67 | 4.7 | 6.81 | 7.3 | 8.7 |
| EV/FCF | -31.4 | 8.9 | 6.03 | 8.58 | 14.44 | 14.48 | 16.24 |
Income Statement
| 2022 | 2023 | 2024 | 2025 | 2026 (e) | 2027 (e) | 2028 (e) | |
|---|---|---|---|---|---|---|---|
| Revenue | 690.4 | 720.0 | 704.5 | 652.3 | 583.8 | 593.6 | 590.4 |
| Rev. Growth, % | 19.5 | 4.3 | -2.2 | -7.4 | -10.5 | 1.7 | -0.5 |
| Ebit | 8.9 | 20.6 | 48.5 | 52.8 | 47.1 | 46.2 | 41.9 |
| Ebit Growth, % | -68.1 | 131.5 | 135.4 | 8.9 | -10.8 | -1.9 | -9.3 |
| Ebit, % | 1.3 | 2.9 | 6.9 | 8.1 | 8.1 | 7.8 | 7.1 |
| Profit | 7.6 | 4.6 | 30.1 | 38.6 | 36.7 | 36.9 | 33.6 |
| EPS | 0.34 | 0.2 | 1.34 | 1.72 | 1.63 | 1.64 | 1.49 |
| Profit Growth, % | -60.0 | -39.5 | 554.3 | 28.2 | -4.9 | 0.5 | -8.9 |
| Profit, % | 1.1 | 0.6 | 4.3 | 5.9 | 6.3 | 6.2 | 5.7 |
Balance Sheet
| 2022 | 2023 | 2024 | 2025 | 2026 (e) | 2027 (e) | 2028 (e) | |
|---|---|---|---|---|---|---|---|
| Inventory | 4.3 | 4.5 | 4.5 | 4.0 | 4.1 | 4.1 | 4.1 |
| Acc. Receivable | 76.8 | 61.5 | 61.2 | 55.1 | 55.4 | 56.2 | 56.8 |
| Cash | 13.1 | 24.5 | 30.9 | 30.7 | 31.8 | 64.4 | 91.6 |
| Equity | 124.0 | 148.0 | 169.0 | 192.6 | 193.5 | 230.4 | 263.9 |
| ROE, % | 6.1 | 3.1 | 17.8 | 20.0 | 19.0 | 16.0 | 12.7 |
| ROCE, % | 1.7 | 3.9 | 9.8 | 10.7 | 9.6 | 8.8 | 7.5 |
| Net Debt | 385.7 | 352.7 | 296.6 | 271.7 | 265.8 | 233.2 | 205.9 |
| Gearing, % | 311.0 | 238.3 | 175.5 | 141.1 | 137.4 | 101.2 | 78.0 |
| Equity ratio, % | 18.7 | 22.5 | 26.8 | 32.2 | 33.0 | 38.0 | 42.5 |
| Acc. Payable | 127.5 | 125.3 | 121.1 | 88.7 | 76.1 | 77.2 | 74.9 |
| Total Assets | 661.6 | 657.5 | 630.2 | 598.1 | 586.5 | 605.7 | 621.2 |
| ROA, % | 1.1 | 0.7 | 4.8 | 6.5 | 6.3 | 6.1 | 5.4 |
Cash Flow
| 2022 | 2023 | 2024 | 2025 | 2026 (e) | 2027 (e) | 2028 (e) | |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 65.0 | 75.9 | 100.7 | 75.6 | 48.4 | 46.1 | 40.9 |
| Investment Cash Flow | -83.4 | -18.4 | -12.4 | -5.7 | -13.6 | -13.6 | -13.6 |
| Free Cash Flow | -18.4 | 57.5 | 88.3 | 69.9 | 34.8 | 32.5 | 27.3 |
| OCF/CAPEX | 0.78 | 4.13 | 8.12 | 13.26 | 3.56 | 3.39 | 3.01 |
| Financial Cash Flow | 27.4 | -49.1 | -82.1 | -70.1 | -33.6 | 0.0 | 0.0 |
Disclaimer
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
The data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.
Contact: quant@quantfactory.eu